Immune response in bladder cancer.
D000917:Antibody Formation; D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D012882:Skin Tests; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery